Skip to main content

Table 4 Change in visual functions between pretreatment evaluation and final evaluation in AVPM

From: Neuro-ophthalmologic outcomes of standard versus hypo-fractionated stereotactic radiotherapy of AVPM

Radiotherapy regimen   Final LogMAR (worse eye) minus pretreatment LogMAR (worse eye) Final MD (worse eye) minus pretreatment MD (worse eye) Final LogMAR (better eye) minus pretreatment LogMAR (better eye) Final MD (better eye) minus pretreatment MD (better eye)
cFSRT p-value* 0.726 0.034 0.740 0.434
   (n = 35) (n = 16) (n = 33) (n = 21)
hSRT p-value* 0.068 0.715 0.893 0.686
   (n = 13) (n = 4) (n = 12) (n = 5)
  1. cFSRT conventionally fractionated stereotactic radiotherapy; hSRT hypofractionated stereotactic radiotherapy; LogMAR logarithm of minimum angle of resolution; MD mean deviation
  2. *Wilcoxon's signed-rank test, two-tailed